The Muscle Mag
Understanding the importance of different types of peptides and when they are crucial is not only essential in wallabies but also in humans. Wallaby milk is abundant in peptides, which are short chains of amino acids known for providing immunological protection to offspring. Khaldi mentioned that she was curious about which plants and their peptides could offer similar biological benefits for humans.
AI plays a significant role in addressing questions about timing and application, requiring not just clinical trials but also a considerable amount of computing power.
“During the last seven years, Nuritas has developed a library containing peptides from various plant sources, which has allowed us to understand the potential biological benefits,” stated Andy Franklyn Miller, the chief medical and innovation officer at Nuritas.
The company’s AI platform, the Nuritas AI Magnifier, has the capability to shorten the research and development time from years to just a few days.
How the AI works
The AI magnifier identifies specific peptide sequences within plants and converts them into ingredients for consumers. Nuritas takes plants, processes them, and creates a database of plant sources and peptides through various biochemical processes and mass spectroscopy.
With over 200 million biological experiments conducted on peptides in their library, Nuritas aims to fully comprehend their functions.
“Our platform stands out for having six years of real-world data, which makes our multiple food sources unique,” Miller mentioned. “We have developed a peptide library that is not easily replicable.”
To create their muscle-building supplement PeptiStrong, researchers at Nuritas focused on identifying peptides that positively impact muscle health while ensuring survivability in the gut.
In addition to cataloging peptides, they utilized AI to predict the most effective paths for enhancing gut survivability.
“Peptides are effective when injected, but ensuring their oral availability required the use of AI models to guarantee survival through digestion,” Miller explained.
Nuritas aims to minimize risk by determining the efficacy of these peptides. The AI Magnifier is currently 64% successful in identifying peptide networks that serve specific functions.
“Finding new ingredients is usually challenging and costly due to a high failure rate, but our platform aims to minimize these risks,” Miller stated.
Partnerships
Nuritas’ business model consists of utilizing their AI technology to advance product development for other companies and enhance their own portfolio. They have collaborated on various products, including muscle-building supplements and ingredients that aid in improving sleep latency.
One recent partnership with Swiss manufacturer Givaudan aims to identify natural peptide solutions to enhance flavor and taste innovations.
The collaboration is expected to generate results within a week through initial AI analysis.
Besides Givaudan, Nuritas has collaborated with other companies, such as Sumitomo Chemical, to address global challenges related to food production sustainably.
Nuritas plans to expand its portfolio to include 30 ingredients in the next decade.
